1. Home
  2. DYN

DYN

Dyne Therapeutics Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-17-2024 12:02pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Founded: 1984 Country:
United States
United States
Employees: 141 City: WALTHAM
Market Cap: 2.1B IPO Year: 2020
Target Price: $37.38 AVG Volume (30 days): 1.4M
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.95 EPS Growth: N/A
52 Week Low/High: $6.40 - $30.27 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: